Nevertheless, the frequency of activated CX3CR1+ CD8+ T cells was higher (P=0.056) in adult COVID-19 patients with suspected or confirmed thrombotic complications (Fig. 3L). The gene discussed is CX3CR1; the disease is COVID-19.